MedDataX Logo

Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

NCT ID: NCT00483795

Last Updated: 2007-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corneal Staining

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18 yrs or older
* Males or females
* Any race or ethnic background
* CL patients using (multipurpose solutions) MPS
* Patients using Acuvue 2 lenses

Exclusion Criteria

* Corneal refractive surgery within 6 months of this study.
* Contact lens use on day of examination.
* Corneal ectasia.
* Current use of Restasis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Innovative Medical

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Kislan, OD

Role: PRINCIPAL_INVESTIGATOR

Hazleton Eye Specialists

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hazleton Eye Specialists

Hazleton, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5308

Identifier Type: -

Identifier Source: org_study_id